OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex biologics. Optimizing these processes involves adjusting various variables, including cell line development, media formulation, and bioreactor settings. A key goal is to maximize antibody yield while lowering production costs